RBF Symposium

Day 1 : February 3, 2009

09.00 hr	Inauguration ceremony
09.05 hr	Welcome Shri. Pankaj Patel, Chairman, Zydus Group
09.15 hr	Chief-Guest Padma Bhushan Dr. K. K. Talwar, Director PGIMER, Chandigarh
09.35 hr	Vote of thanks Dr. Ganesh Nayak, Executive Director, Zydus Cadila

Session I

Chairpersons

Dr. Jeffrey M. Friedman, Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA
Dr. Richard DiMarchi, Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University

09.40 to 10.15 hrs

Keynote address

Dr. Roger Newton
Co-founder of Esperion Therapeutics, USA
[ Co-Discoverer of Lipitor(R) ]

10.15 to 11.00 hrs

Coffee break

11.00 to 11.45 hrs

Plenary Lecture
(PL-1)

“Emerging therapeutic strategy for cardiovascular disease – adipocytokines”

Dr. Yuji Matsuzawa
Director, Sumitomo Hospital,
Professor Emeritus, Osaka University, Japan

11.45 to 12.30 hrs

Plenary Lecture
(PL-2)

"Systemic Biomarkers in Atherosclerosis: New Horizons"

Dr. John Chapman
President Elect, European Atherosclerosis Society
Director, Dyslipidemia and Atherosclerosis Research Unit,
INSERM, France

12.30 to 13.15 hrs

Invited Lecture
(IL-1)

“Current understanding of the off-target activity of torcetrapib”

Dr. Eric Niesor
Metabolic & Vascular Disease Area,
Roche AG, Switzerland

13.15 to 14.30 hrs

Lunch

Session II
Chairpersons Dr. Per-Olof Berggren, The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Sweden Prof. P. Rama Rao, Director, National Institute of Pharmaceutical Education and Research (NIPER), India
14.30 - 15.15 hr	Plenary Lecture (PL-3)	“Inflammation as a marker and a target to reduce atherosclerosis related cardiovascular events” Prof. François Mach Head of Cardiology Geneva University Hospital, Switzerland
15.15 - 16.00 hr	Plenary Lecture (PL-4)	“Metabolic Approaches for treatment of ischaemia” Dr. S.C. Manchanda Senior consultant cardiologist, Sir Ganga Ram Hospital, Delhi Formerly Prof. And Head, dept. Of cardiology, AIIMS
16.00 – 17.00 hr	Poster presentation and networking
17.00 to 17.45 hr	Invited Lecture (IL-2)	"Predictive metabolomic, lipomic and transcriptomic profiling of peripheral blood" Dr. Charles Burant Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA
17.00 to 18.30 hrs	Panel discussion	Chairperson: Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University; Retired Group Vice President, Eli Lilly & Company, USA Dr. Roger Newton Co-founder of Esperion Therapeutics, USA [ Co-Discoverer of Lipitor(R) ] Dr. Yuji Matsuzawa Director, Sumitomo Hospital, Professor Emeritus, Osaka University, Japan Dr. Eric Niesor Metabolic & Vascular Disease Area, F. Hoffmann-La Roche AG Dr. John Chapman President Elect, European Atherosclerosis Society Prof. François Mach Head of CardiologyGeneva University Hospital, Switzerland Dr. S.C. Manchanda Senior consultant cardiologist, Sir Ganga Ram Hospital, Delhi Formerly Prof. And Head, dept. Of cardiology, AIIMS Dr. Charles Burant Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA

Day 2 : February 4, 2009
Session III
Chairpersons Dr. Y. K. Gupta, All India Institute of Medical Sciences (AIIMS), India Dr. John Chapman, President Elect, European Atherosclerosis Society
09.00 to 9.45 hrs	Keynote address	"Energy Medicine-a new Vista" Prof. B. M. Hegde MD, FRCP, FRCPE, FRCPG, FRCPI, FACC, FAMS. Retd. Vice Chancellor, Manipal University, India Visiting Prof. Cardiology, The Middlesex Hospital Medical School, University of London, Affiliate Prof. of Human Health, Northern Colorado University,
09.45 to 10.30 hrs	Plenary Lecture (PL-5)	“Mipomersen: A Novel Lipid Lowering Drug, From the Bench to the Clinic” Dr. Sanjay Bhanot Metabolic Franchise Leader Vice President, Metabolic Diseases Research & Development Isis Pharmaceuticals Inc., USA
10.30 to 11.00 hrs	Coffee break
11.00 to 11.45 hrs	Invited Lecture (IL-3)	“Eprotirome: A novel and physiological approach to CVD risk reduction” Dr. Jens Kristensen, MD, Dr Med Sci, PhD VP Clinical Development Chief Medical Officer Karo Bio AB, Sweden
11.45 to 12.30 hrs	Invited Lecture (IL-4)	“Targeting Protein Kinase C to treat Ischemia-Reperfusion Damage in the Heart” Dr. Steve Harrison Vice President, Research KAI Pharmaceuticals
12.30 to 13.15 hrs	Plenary Lecture (PL-6)	"PPARα and β/δ orchestrate hepatic and pancreatic functions" Dr. Walter Wahli Founder Director, Centre for Integrative Genomics, Switzerland
13.15 to 14.30 hrs	Lunch

Session IV
Chairpersons Dr. N. K. Ganguly, Former Director General, Indian Council of Medical Research (ICMR) Dr. B.Sesikeran, Director, National Institute of Nutrition, Hyderabad, India
14.30 - 15.15 hr	Keynote Address	"Leptin and the Homeostatic Control of Energy Balance" Dr. Jeffrey M. Friedman Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA
15.15 - 16.00 hr	Plenary Lecture (PL-7)	“Gut - Brain Communication in the Control of Metabolism” Dr. Matthias H. Tschöp Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA
16.00 – 17.30 hr	Coffee Break Poster presentation and networking
17.30 to 18.15 hr	Invited Lecture (IL-5)	"Stem cell therapy and diabetes" Dr. Anil Bhansali Professor & Head, Endocrinology, Postgraduate Institute of Medical Education & Research, Chandigarh
18.15 to 19.00 hrs	Panel discussion	Chairperson: Dr. Roger Newton Co-founder of Esperion Therapeutics, USA [ Co-Discoverer of Lipitor(R) ] Prof. B. M. Hegde Retd. Vice Chancellor, Manipal University, India Visiting Prof. Cardiology, The Middlesex Hospital Medical School, University of London. Affiliate Prof. of Human Health, Northern Colorado University, Dr. Sanjay Bhanot Metabolic Franchise Leader, Vice President, Metabolic Diseases Research & Development, Isis Pharmaceuticals Inc., USA Jens Kristensen, MD, Dr Med Sci, PhD. VP Clinical Development, Chief Medical Officer, Karo Bio AB, Sweden Dr. Steve Harrison Vice President, Research, KAI Pharmaceuticals Dr. Walter Wahli Founder Director, Centre for Integrative Genomics, Switzerland Dr. Matthias H. Tschöp Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA Dr. Jeffrey M. Friedman Marilyn M. Simpson Professor; Investigator, HHMI, Rockefeller University, USA Dr. Anil Bhansali Professor & Head, Endocrinology, Postgraduate Institute of Medical Education & Research, Chandigarh
19.00 - 20.00 hr	Cultural Program
20.00 - 21.00 hr	Dinner

Day 3 : February 5, 2009
Session V
Chairpersons Dr. Yuji Matsuzawa Director, Sumitomo Hospital, Professor Emeritus, Osaka University, Japan Dr. Charles Burant, Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA
09.00 to 9.45 hrs	Keynote address	“Molecular mechanisms of antidiabetic effects of estrogen” Dr. Suad Efendic Professor, Karolinska Institutet, Sweden
09.45 to 10.15 hrs	Plenary Lecture (PL-8)	"SGLT2 Inhibition: A Novel Approach to the Treatment of Type 2 Diabetes" Dr. Jean Whaley Director, Diabetes Drug Discovery Bristol-Myers Squibb, USA
10.15 to 10.45 hrs	Coffee break
11.45 to 11.30 hrs	Invited Lecture (IL-6)	Dr. R. K. Goyal Vice Chancellor, MS University, Baroda, India
11.30 to 12.15 hrs	Plenary Lecture (PL-9)	“Signal-Transduction in the Endocrine Pancreas” Dr. Per-Olof Berggren The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Sweden
12.15 to 13.30 hrs	Lunch

Session VI
Chairpersons Dr. R. K. Goyal, Vice Chancellor, M. S. University, India Dr. Matthias H. Tschöp, Associate Professor, Departments of Psychiatry and Medicine, Obesity Research Centre/Genome Research Institute, University of Cincinnati, College of Medicine, USA
13.30 - 14.15 hr	Invited Lecture (IL-7)	Dr. Ho Cho Vice President, Ambrx, USA
14.15 - 15.00 hr	Keynote address	“Beyond Small Molecules: The Use of Biologics in the Treatment of Metabolic Disorders” Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University Retired Group Vice President, Eli Lilly & Company, USA
15.00 - 15.30 hr	Oral Presentation - I ( 15 mins) Oral Presentation - II ( 15 mins)
15.30 to 16.15 hrs	Panel discussion	Chairperson: Dr. Charles Burant, Dr. Robert C. and Veronica Atkins Professor of Metabolism, University of Michigan, USA Dr. Richard DiMarchi Linda & Jack Gill Chair in Biomolecular Sciences and Professor of Chemistry, Indiana University Retired Group Vice President, Eli Lilly & Company, USA Dr. Suad Efendic Professor, Karolinska Institutet, Sweden Dr. Per-Olof Berggren The Rolf Luft Research Center for Diabetes and Endocrinology, Karolinska Institutet, Sweden Dr. R. K. Goyal Vice Chancellor, MS University, Baroda, India Dr. Jean Whaley Director, Diabetes Drug Discovery, Bristol-Myers Squibb, USA Dr. Ho Cho Vice President, Ambrx, USA
16.30 - 17.00 hr	Closing Remarks Pankaj Patel, Chairman & Managing Director, Zydus Cadila